fluconazole has been researched along with levofloxacin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 20 (68.97) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Aytemir, MD; Ozçelik, B | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, PJ; Gu, YF; He, P; Liu, HM; Ren, JL; Shan, LH; Shao, KP; Xue, DQ; Zhang, QR | 1 |
| Chen, PJ; Gu, YF; He, P; Jiang, TF; Liu, HM; Shao, KP; Xue, DQ; Yang, A; Zhang, QR; Zhang, XS | 1 |
| Chopra, S; Kushwaha, P; Modukuri, RK; Pasupuleti, M; Rao, KB; Sashidhara, KV; Shukla, PK; Singh, P; Soni, I | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bahekar, SS; Jawale, CS; Karnik, KS; Pansare, DN; Pawar, CD; Sarkate, AP; Shelke, RN; Shinde, DB | 1 |
| Zhang, B | 1 |
| Ji, Q; Li, B; Shen, Y; Wang, K; Zhang, R | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Liu, H; Long, S; Rakesh, KP; Zha, GF | 1 |
| Avorn, J; Fischer, MA; Solomon, DH; Teich, JM | 1 |
| Gandhi, PJ; Menezes, PA; Ramaswamy, K; Rivera, AL; Vu, HT | 1 |
| Bai, XQ; Deng, SJ; Li, R; Liang, QF; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Estes, LL; Wilson, JW; Zeuli, JD | 1 |
| Ansari, FL; Ashraf, Z; Baseer, M | 1 |
| Foulon, V; Spriet, I; Vandael, E; Vandenberghe, J; Vandenberk, B; Willems, R | 1 |
| Groo, VL; Sadr, R; Tilton, JJ | 1 |
| Dȩbowski, D; Gitlin-Domagalska, A; Gucwa, K; Milewski, S; Okońska, J; Olkiewicz, K; Ptaszyńska, N; Rolka, K; Ruczyński, J; Łȩgowska, A | 1 |
| Arif, S; Bishawi, M; Maskarinec, SA; Milano, C; Miller, RA; Mourad, A | 1 |
| Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
4 review(s) available for fluconazole and levofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Triazines; Viruses | 2020 |
25 other study(ies) available for fluconazole and levofloxacin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Bacteria; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Fungi; Herpesvirus 1, Human; Mannich Bases; Microbial Sensitivity Tests; Parainfluenza Virus 3, Human; Pyrones; Spectrum Analysis; Vero Cells | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and antimicrobial activities of novel 1,2,4-triazolo [3,4-a] phthalazine derivatives.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Phthalazines; Staphylococcus aureus; Structure-Activity Relationship; Triazoles | 2014 |
Synthesis, in vitro antimicrobial and cytotoxic activities of novel pyrimidine-benzimidazol combinations.
Topics: Anti-Infective Agents; Bacteria; Benzimidazoles; Candida albicans; Cell Line, Tumor; Cell Survival; Combinatorial Chemistry Techniques; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines | 2014 |
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
Topics: | 2015 |
Synthesis and antimicrobial evaluation of novel ethyl 2-(2-(4-substituted)acetamido)-4-subtituted-thiazole-5-carboxylate derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Aspergillus niger; Bacillus subtilis; Candida albicans; Carboxylic Acids; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2016 |
Design, synthesis and biological evaluation of novel diazaspiro[4.5]decan-1-one derivatives as potential chitin synthase inhibitors and antifungal agents.
Topics: Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aza Compounds; Candida albicans; Chitin Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Ketones; Microbial Sensitivity Tests; Molecular Structure; Spiro Compounds; Structure-Activity Relationship | 2019 |
Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.
Topics: Administration, Oral; Amiodarone; Drug Therapy, Computer-Assisted; Fluconazole; Humans; Infusions, Intravenous; Levofloxacin; Medication Systems, Hospital; Metronidazole; Ofloxacin; Practice Patterns, Physicians'; Ranitidine; Reminder Systems | 2003 |
Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient.
Topics: Anti-Infective Agents; Antifungal Agents; Fluconazole; Humans; Intensive Care Units; Levofloxacin; Male; Middle Aged; Monitoring, Physiologic; Ofloxacin; Torsades de Pointes; United States | 2003 |
[Etiological analysis of ocular non-viral microbial isolates in children and their antibiotics susceptibility in vitro].
Topics: Adolescent; Anti-Infective Agents; Bacteria; Child; Child, Preschool; Drug Resistance, Microbial; Eye Infections; Female; Fluconazole; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Microbial Sensitivity Tests; Mitosporic Fungi; Ofloxacin; Retrospective Studies; Rifampin | 2009 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Synthesis, in vitro antibacterial and antifungal activity of some n-acetylated and non-acetylated pyrazolines.
Topics: Acetic Acid; Acetylation; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Chalcones; Fluconazole; Hydrazines; Levofloxacin; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Ofloxacin; Pyrazoles; Spectroscopy, Fourier Transform Infrared | 2013 |
Development of a risk score for QTc-prolongation: the RISQ-PATH study.
Topics: Aged; Female; Fluconazole; Haloperidol; Humans; Levofloxacin; Long QT Syndrome; Male; Models, Statistical; Predictive Value of Tests; Risk Factors; ROC Curve | 2017 |
Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
Topics: Adult; Electrocardiography; Female; Fluconazole; Humans; Levofloxacin; Long QT Syndrome; Risk Factors; Torsades de Pointes | 2019 |
Antibiotic-Based Conjugates Containing Antimicrobial HLopt2 Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Ciprofloxacin; Drug Stability; Escherichia coli; Fluconazole; HEK293 Cells; Hep G2 Cells; Humans; Immunoconjugates; Lactoferrin; Levofloxacin; Male; Microbial Sensitivity Tests; Peptide Fragments; Staphylococcus aureus; Swine | 2019 |
Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Cephalosporins; Cross-Sectional Studies; Drug Therapy, Combination; Fluconazole; Heart-Assist Devices; Humans; Levofloxacin; Prosthesis Implantation; Prosthesis-Related Infections; Rifampin; Surgical Wound Infection; Surveys and Questionnaires; Vancomycin | 2020 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |